ZiggaZagga

Three Potential Biotech Takeover Targets

What does this piece say that hasn't already been said and speculated in the last 18 months? These are all the usual suspects. However all these companies have large market capitals and would require a hefty premium to purchase. The cheapest would be Biogen at 20-25 billion dollars. Only one company has that much cash and most of it is stuck outside the US. You could be waiting a very long time if you're betting on any of these candidates. A much more interesting article would have been to look at companies with market capitals of less than 2.5 billion. These are the more likely take over candidates and premiums can be as high as 500% for some. e.g. Sitris